ACRO Biomedical Co Stock

ACRO Biomedical Co Operating Expenses

The Total Operating Expenses of ACRO Biomedical Co (6748.TWO) as of Aug 18, 2026 is 111.41 M TWD. In the previous year, Total Operating Expenses was 72.37 M TWD — a change of 53.94% (higher).

Operating Expenses

111.41 MTWD

YoY

53.94%

Last updated:

Total Operating Expenses of ACRO Biomedical Co is 2026 111.41 M TWD. Total Operating Expenses of ACRO Biomedical Co was 2025 72.37 M TWD. It decreases by 53.94% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

ACRO Biomedical Co Stock analysis

What does ACRO Biomedical Co do? ACRO Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ACRO Biomedical Co stock

Total Operating Expenses of ACRO Biomedical Co is 111.41 M TWD in 2026.

Total Operating Expenses of ACRO Biomedical Co changed from 72.37 M TWD to 111.41 M TWD, representing a 53.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses ACRO Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's ACRO Biomedical Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — ACRO Biomedical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — ACRO Biomedical Co